Additionally, the tumor is strongly positive for both MYC and BCL6, classifying it as double-hit lymphoma, or the double-expressor type, which is associated with an extremely poor prognosis and a median survival of 12-18 months [17]. The gene discussed is BCL6; the disease is neoplasm.